A comparative study of the hypolipidemic effects and mechanisms of action of Laminaria japonica - and Ascophyllum nodosum -derived fucoidans in apolipoprotein E-deficient mice

The structural characteristics of fucoidans exhibit species and regional diversity. Previous studies have demonstrated that - and -derived fucoidans have type I and type II fucosyl chains, respectively. These chemical differences may contribute to distinct hypolipidemic effects and mechanisms of act...

Full description

Saved in:
Bibliographic Details
Published inFood & function Vol. 15; no. 11; pp. 5955 - 5971
Main Authors Liu, Tian, Wang, Xue, Wang, Yan-Ming, Sui, Feng-Rong, Zhang, Xue-Ying, Liu, Hai-Di, Ma, Dong-Yue, Liu, Xiao-Xiao, Guo, Shou-Dong
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 04.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The structural characteristics of fucoidans exhibit species and regional diversity. Previous studies have demonstrated that - and -derived fucoidans have type I and type II fucosyl chains, respectively. These chemical differences may contribute to distinct hypolipidemic effects and mechanisms of action. Chemical analysis demonstrated that the percentage contents of sulfate, glucuronic acid, and galactose were higher in -derived fucoidans than those of -derived fucoidans. In hyperlipidemic apolipoprotein E-deficient mice, both - and -derived fucoidans significantly decreased the plasma and hepatic levels of total cholesterol and triglyceride, leading to the reduction of atherosclerotic plaques. Western blotting experiments demonstrated that these fucoidans significantly enhanced the expression and levels of scavenger receptor B type 1, cholesterol 7 alpha-hydroxylase A1, and peroxisome proliferator-activated receptor (PPAR)-α, contributing to circulating lipoprotein clearance and fatty acid degradation, respectively. Differentially, -derived fucoidan significantly increased the LXR/ATP-binding cassette G8 signaling pathway in the small intestine, as revealed by real-time quantitative PCR, which may lead to further cholesterol and other lipid excretion. Collectively, these data are useful for understanding the hypolipidemic mechanisms of action of seaweed-derived fucoidans, and their potential application for the prevention and/or treatment of atherosclerotic cardiovascular diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2042-6496
2042-650X
2042-650X
DOI:10.1039/d3fo05521c